Unveiling the Role of the Most Impactful Cardiovascular Risk Locus through Haplotype Editing
Open accessThe DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Abstract
SUMMARY The 9p21.3 cardiovascular disease locus is the most influential common genetic risk factor for coronary artery disease (CAD), accounting for ~10%−15% of disease in non-African populations. The ~60 kb risk haplotype is human-specific and lacks coding genes, hindering efforts to decipher its function. Here, we produce induced pluripotent stem cells (iPSCs) from risk and non-risk individuals, delete each haplo-type using genome editing, and generate vascular smooth muscle cells (VSMCs). Risk VSMCs exhibit globally altered transcriptional networks that intersect with previously identified CAD risk genes and pathways, concomitant with aberrant adhesion, contraction, and proliferation. Unexpectedly, deleting the risk haplotype rescues VSMC stability, while expressing the 9p21.3-associated long non-coding RNA ANRIL induces risk phenotypes in non-risk VSMCs. This study shows that the risk haplotype selectively predisposes VSMCs to adopt a cell state associated with CAD phenotypes, defines new VSMC-based networks of CAD risk genes, and es-tablishes haplotype-edited iPSCs as powerful tools for functionally annotating the human genome.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2
Love, M. I., Huber, W., & Anders, S. (2014) · Genome Biology · doi:10.1186/s13059-014-0550-8 · Cited by 95,106
Integrative Genomics Viewer (IGV): high-performance genomics data visualization and exploration
Thorvaldsdottir, H., Robinson, J. T., & Mesirov, J. P. (2013) · Briefings in Bioinformatics · doi:10.1093/bib/bbs017 · Cited by 9,049 · cited 3×
“For identification of ANRIL splicing junctions, we used samtools 1.3 (Li et al., 2009) to pool STAR aligned reads and IGV 2.3.80 (Integrative Genomics Viewer) (Thorvaldsdóttir et al., 2013) for visualization.”
InfluentialLeek, J. T., Johnson, W. E., Parker, H. S., Jaffe, A. E., & Storey, J. D. (2012) · Bioinformatics · doi:10.1093/bioinformatics/bts034 · Cited by 6,231
Causal analysis approaches in Ingenuity Pathway Analysis
Krämer, A., Green, J., Pollard, J., & Tugendreich, S. (2014) · Bioinformatics · doi:10.1093/bioinformatics/btt703 · Cited by 5,724 · cited 2×
“com/products/ingenuity-pathway-analysis/) (Krämer et al., 2014).”
Full-length RNA-seq from single cells using Smart-seq2
Picelli, S., Faridani, O. R., Björklund, Å. K., Winberg, G., Sagasser, S., & Sandberg, R. (2014) · Nature Protocols · doi:10.1038/nprot.2014.006 · Cited by 4,137 · cited 2×
“…N/A SMARTseq2-(dT)30 (5 0 AAGCAGTGGTATCAACGCA GAGTACT30 3 0) Picelli et al., 2014 N/A Template switch oligo (50AAGCAGTGGTATCAACGCA GAGTACATrGrG+G 30) Picelli et al., 2014 N/A Recombinant DNA pCXLE-hOCT3/4-shp53 Addgene ID: 27077 pCXLE-hSK Addgene ID: 27078 (Continued on next page) Cell 175,…”
Progress and challenges in translating the biology of atherosclerosis
Libby, P., Ridker, P. M., & Hansson, G. K. (2011) · Nature · doi:10.1038/nature10146 · Cited by 4,010 · cited 1×
“, 2007), CAD is also accompanied by the accumulation of inflammatory foam cells in atherosclerotic plaques (Libby et al., 2011).”
A comprehensive 1000 Genomes–based genome-wide association meta-analysis of coronary artery disease
the CARDIoGRAMplusC4D Consortium (2015) · Nature Genetics · doi:10.1038/ng.3396 · Cited by 2,447
Vascular smooth muscle cells in atherosclerosis
Bennett, M. R., Sinha, S., & Owens, G. K. (2016) · Circulation Research · doi:10.1161/circresaha.115.306361 · Cited by 2,179 · cited 4×
“contractile and adhesive, and play key roles in plaque formation and stability (Alexander and Owens, 2012; Bennett et al., 2016).”
InfluentialA TALE nuclease architecture for efficient genome editing
Miller, J. C., Tan, S., Qiao, G., Barlow, K. A., Wang, J., Xia, D. F., Meng, X., Paschon, D. E., Leung, E., Hinkley, S. J., et al. (2011) · Nature Biotechnology · doi:10.1038/nbt.1755 · Cited by 2,098 · cited 2×
“Genome editing, transfection, genotyping Transcription activator-like effector nucleases (TALENs) for the 9p21 CAD risk region were designed using an archive of TALE modules as described (Miller et al., 2011), and cloned into a mammalian expression vector as fusions to obligate heterodimer forms of the FokI endonuclea…”
Self-citationGenomewide Association Analysis of Coronary Artery Disease
Samani, N. J., Erdmann, J., Hall, A. S., Hengstenberg, C., Mangino, M., Mayer, B., Dixon, R. J., Meitinger, T., Braund, P., Wichmann, H.-E., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa072366 · Cited by 2,044
A Common Variant on Chromosome 9p21 Affects the Risk of Myocardial Infarction
Helgadottir, A., Thorleifsson, G., Manolescu, A., Gretarsdottir, S., Blondal, T., Jonasdottir, A., Jonasdottir, A., Sigurdsson, A., Baker, A., Palsson, A., et al. (2007) · Science · doi:10.1126/science.1142842 · Cited by 1,594 · cited 1×
“3 chromosomal region linked to several CVDs, including CAD, stroke, and aneurysms (Burton et al., 2007; Helgadottir et al., 2007;McPherson and Tybjaerg-Hansen, 2016; McPherson et al., 2007; Nikpay et al., 2015; Samani et al., 2007).”
A Common Allele on Chromosome 9 Associated with Coronary Heart Disease
McPherson, R., Pertsemlidis, A., Kavaslar, N., Stewart, A., Roberts, R., Cox, D. R., Hinds, D. A., Pennacchio, L. A., Tybjaerg-Hansen, A., Folsom, A. R., et al. (2007) · Science · doi:10.1126/science.1142447 · Cited by 1,587 · cited 1×
“3 chromosomal region linked to several CVDs, including CAD, stroke, and aneurysms (Burton et al., 2007; Helgadottir et al., 2007;McPherson and Tybjaerg-Hansen, 2016; McPherson et al., 2007; Nikpay et al., 2015; Samani et al., 2007).”
Genome Engineering with Targetable Nucleases
Carroll, D. (2014) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-060713-035418 · Cited by 568 · cited 1×
“Therefore, our goal was to delete the entire haplotype (referred to as haplotype editing) (Carroll, 2014).”
CD36, a scavenger receptor implicated in atherosclerosis
Park, Y. M. (2014) · Experimental & Molecular Medicine · doi:10.1038/emm.2014.38 · Cited by 517
Mumbach, M. R., Satpathy, A. T., Boyle, E. A., Dai, C., Gowen, B. G., Cho, S. W., Nguyen, M. L., Rubin, A. J., Granja, J. M., Kazane, K. R., et al. (2017) · Nature Genetics · doi:10.1038/ng.3963 · Cited by 490 · cited 1×
“3 risk haplotype associated more strongly with the ANRIL enhancer (and also with the nearby CDKN2B enhancer) compared to the analogous region in the non-risk haplotype (Mumbach et al., 2017).”
Enhancing zinc-finger-nuclease activity with improved obligate heterodimeric architectures
Doyon, Y., Vo, T. D., Mendel, M. C., Greenberg, S. G., Wang, J., Xia, D. F., Miller, J. C., Urnov, F. D., Gregory, P. D., & Holmes, M. C. (2011) · Nature Methods · doi:10.1038/nmeth.1539 · Cited by 402
Self-citationHoldt, L. M., Hoffmann, S., Sass, K., Langenberger, D., Scholz, M., Krohn, K., Finstermeier, K., Stahringer, A., Wilfert, W., Beutner, F., et al. (2013) · PLoS Genetics · doi:10.1371/journal.pgen.1003588 · Cited by 397 · cited 2×
“Indeed, the number of differentially regulated genes we have uncovered ( 3,000) (Table S6) is significantly greater than those reported using gene chip-based profiling of human cell lines ( 200–700) (Holdt et al., 2013).”
Influence of donor age on induced pluripotent stem cells
Lo Sardo, V., Ferguson, W., Erikson, G. A., Topol, E. J., Baldwin, K. K., & Torkamani, A. (2017) · Nature Biotechnology · doi:10.1038/nbt.3749 · Cited by 223
Motterle, A., Pu, X., Wood, H., Xiao, Q., Gor, S., Liang Ng, F., Chan, K., Cross, F., Shohreh, B., Poston, R. N., et al. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds224 · Cited by 160 · cited 3×
“Rather, association studies suggest that this risk haplotype acts to promote early events leading to atherosclerotic plaque formation (Bennett et al., 2016; Miller et al., 2016; Motterle et al., 2012).”
Hannou, S. A., Wouters, K., Paumelle, R., & Staels, B. (2015) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2015.01.008 · Cited by 159
Expression of Chr9p21 genes CDKN2B (p15), CDKN2A (p16, p14) and MTAP in human atherosclerotic plaque
Holdt, L. M., Sass, K., Gäbel, G., Bergert, H., Thiery, J., & Teupser, D. (2011) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2010.06.029 · Cited by 143 · cited 1×
“…in splice isoforms can depend on the cell type and state, this leads to difficulties in directly comparing studies using different ANRIL primer sets in different cell lineages (Hannou et al., 2015; Holdt and Teupser, 2012; Holdt et al., 2011, 2013; Jarinova et al., 2009; Motterle et al., 2012).”
BackgroundGeneration of a triple-gene knockout mammalian cell line using engineered zinc-finger nucleases
Liu, P., Chan, E. M., Cost, G. J., Zhang, L., Wang, J., Miller, J. C., Guschin, D. Y., Reik, A., Holmes, M. C., Mott, J. E., et al. (2010) · Biotechnology and Bioengineering · doi:10.1002/bit.22654 · Cited by 107
Self-citationThe Myocardial Infarction Genetics Consortium, Shea, J., Agarwala, V., Philippakis, A. A., Maguire, J., Banks, E., DePristo, M., Thomson, B., Guiducci, C., Onofrio, R. C., et al. (2011) · Nature Genetics · doi:10.1038/ng.871 · Cited by 87
Functional Genomics of the 9p21.3 Locus for Atherosclerosis: Clarity or Confusion?
Chen, H.-H., Almontashiri, N. A. M., Antoine, D., & Stewart, A. F. R. (2014) · Current Cardiology Reports · doi:10.1007/s11886-014-0502-7 · Cited by 45 · cited 1×
“Third, although the region encompasses the terminal exons of a long non-coding RNA (lncRNA), ANRIL (also known as CDKN2B-AS1), and is predicted to be enhancer rich, both lncRNA function and enhancer activity are difficult to assess using purely computational tools and are often highly context-dependent (Hannou et al.,…”
Cited by
Vascular smooth muscle cells in atherosclerosis
Basatemur, G. L., Jørgensen, H. F., Clarke, M. C. H., Bennett, M. R., & Mallat, Z. (2019) · Nature Reviews Cardiology · doi:10.1038/s41569-019-0227-9 · Cited by 1,099
Alencar, G. F., Owsiany, K. M., Karnewar, S., Sukhavasi, K., Mocci, G., Nguyen, A. T., Williams, C. M., Shamsuzzaman, S., Mokry, M., Henderson, C. A., et al. (2020) · Circulation · doi:10.1161/circulationaha.120.046672 · Cited by 403
Systems biology in cardiovascular disease: a multiomics approach
Joshi, A., Rienks, M., Theofilatos, K., & Mayr, M. (2021) · Nature Reviews Cardiology · doi:10.1038/s41569-020-00477-1 · Cited by 301
Farooq, U., Saravanan, B., Islam, Z., Walavalkar, K., Singh, A. K., Jayani, R. S., Meel, S., Swaminathan, S., & Notani, D. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.108898 · Cited by 29
Monogenic and Polygenic Models of Coronary Artery Disease
Muse, E. D., Chen, S.-F., & Torkamani, A. (2021) · Current Cardiology Reports · doi:10.1007/s11886-021-01540-0 · Cited by 27
Self-citation
Metadata
- Authors
- Lo Sardo, V., Chubukov, P., Ferguson, W., Kumar, A., Teng, E. L., Duran, M., Zhang, L., Cost, G., Engler, A. J., Urnov, F., Topol, E. J., Torkamani, A., & Baldwin, K. K.
- Venue
- Cell
- Publisher
- Elsevier BV
- Published
- 2018-12
- Volume
- 175
- Issue
- 7
- Pages
- 1796-1810.e20
- ISSN
- 0092-8674 (ISSN-L)
- OpenAlex
- W2904124790
- Cited by
- 124
- References
- 24
- FWCI
- 9.02
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.